2016 | | A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting | 강석윤 |
2019 | | A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer | 고영화, 안미선, 이수진 |
2020 | | A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis | 박준성 |
2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
1996 | | A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis. | 김효철 |
2020 | | A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells | 김철호, 이현우, 정근옥, 함석진 |
2023 | | A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea | 최윤석 |
2011 | | A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database | 감혜진, 강석윤, 박래웅, 박인휘, 이기영 |
2014 | | A novel delivery platform for therapeutic peptides. | 박준성 |
2023 | | A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13) | 안미선 |
2024 | | A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial | 이현우 |
2016 | | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | 정성현 |
2015 | | A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome. | 정성현 |
2017 | | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 박준성, 정성현 |
2021 | | A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer | 최진혁 |
2019 | | A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746) | 강석윤 |
2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
2017 | | A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer | 강석윤 |
2015 | | A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient. | 박준성, 조성란, 한재호 |
2011 | | (A)case of primary central nervous system lymphoma : an unusual presentation with hormonal abnormalities and good prognosis after chemo-radiotherapy | 안소연, 이현우, 정윤석 |